Page last updated: 2024-11-04

sulforaphane and Ataxia

sulforaphane has been researched along with Ataxia in 1 studies

sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.

Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Napoli, E1
Flores, A1
Mansuri, Y1
Hagerman, RJ1
Giulivi, C1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Open-Label Trial of Sulforaphane in Premutation Carriers With FXTAS to Find Biomarkers[NCT05233579]15 participants (Actual)Interventional2021-06-25Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for sulforaphane and Ataxia

ArticleYear
Sulforaphane improves mitochondrial metabolism in fibroblasts from patients with fragile X-associated tremor and ataxia syndrome.
    Neurobiology of disease, 2021, Volume: 157

    Topics: Aged; Aged, 80 and over; Ataxia; Energy Metabolism; Female; Fibroblasts; Fragile X Syndrome; Humans;

2021